Chronic varicella-zoster virus ganglionitis--a possible cause of postherpetic neuralgia
- PMID: 12775423
- DOI: 10.1080/13550280390201722
Chronic varicella-zoster virus ganglionitis--a possible cause of postherpetic neuralgia
Abstract
Postherpetic neuralgia (PHN) is dermatomal distribution pain that persists for months to years after the resolution of herpes zoster rash. The cause of PHN is unknown. Herein, we report clinical, molecular virological, and immunological findings over an 11-year period in an immunocompetent elderly woman with PHN. Initially, blood mononuclear cells (MNCs) contained varicella-zoster virus (VZV) DNA on two consecutive occasions. Random testing after treatment with famciclovir to relieve pain did not detect VZV DNA. However, the patient was reluctant to continue famciclovir indefinitely and voluntarily stopped drug treatment five times. Pain always recurred within 1 week, and blood MNCs contained many, but not all, regions of the VZV genome on all five occasions. Immunological analysis revealed increased cell-mediated immunity to VZV. Chronic VZV ganglionitis-induced PHN best explains the recurrence of VZV DNA in MNCs whenever famciclovir was discontinued; the detection of only some regions of the viral genome in MNCs, compared to the detection of all regions of the VZV genome in latently infected ganglia; the increased cell-mediated immunity to VZV; and a gratifying clinical response to famciclovir. The presence of fragments of VZV DNA in MNCs likely represents partial degradation of viral DNA in MNCs that trafficked through ganglia during productive infection.
Similar articles
-
Varicella virus-mononuclear cell interaction.Adv Virus Res. 2003;62:1-17. doi: 10.1016/s0065-3527(03)62001-4. Adv Virus Res. 2003. PMID: 14719363 Review.
-
VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy.Neurology. 2005 Jan 11;64(1):21-5. doi: 10.1212/01.WNL.0000148484.19070.4D. Neurology. 2005. PMID: 15642898 Review.
-
Patient characteristics and analgesic efficacy of antiviral therapy in postherpetic neuralgia.Med Hypotheses. 2019 Oct;131:109323. doi: 10.1016/j.mehy.2019.109323. Epub 2019 Jul 22. Med Hypotheses. 2019. PMID: 31443749
-
Herpes zoster guideline of the German Dermatology Society (DDG).J Clin Virol. 2003 Apr;26(3):277-89; discussion 291-3. doi: 10.1016/s1386-6532(03)00005-2. J Clin Virol. 2003. PMID: 12637076
-
Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia.Proc Natl Acad Sci U S A. 1988 Apr;85(8):2767-70. doi: 10.1073/pnas.85.8.2767. Proc Natl Acad Sci U S A. 1988. PMID: 2833752 Free PMC article.
Cited by
-
Pathogenesis and current approaches to control of varicella-zoster virus infections.Clin Microbiol Rev. 2013 Oct;26(4):728-43. doi: 10.1128/CMR.00052-13. Clin Microbiol Rev. 2013. PMID: 24092852 Free PMC article. Review.
-
Causal Impact of Immune Phenotypes on Herpes Zoster and Postherpetic Neuralgia: Insights from Mendelian Randomization Analysis.Clin Cosmet Investig Dermatol. 2025 Apr 15;18:919-928. doi: 10.2147/CCID.S502861. eCollection 2025. Clin Cosmet Investig Dermatol. 2025. PMID: 40255632 Free PMC article.
-
Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia.J Intern Med. 2011 May;269(5):496-506. doi: 10.1111/j.1365-2796.2011.02359.x. Epub 2011 Feb 23. J Intern Med. 2011. PMID: 21294791 Free PMC article. Review.
-
Varicella zoster virus infection.Nat Rev Dis Primers. 2015 Jul 2;1:15016. doi: 10.1038/nrdp.2015.16. Nat Rev Dis Primers. 2015. PMID: 27188665 Free PMC article. Review.
-
Zoster-Associated Prothrombotic Plasma Exosomes and Increased Stroke Risk.J Infect Dis. 2023 Apr 18;227(8):993-1001. doi: 10.1093/infdis/jiac405. J Infect Dis. 2023. PMID: 36200236 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources